Recent insider trading activity from Daniel Mark James, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 26, 2026 | ATOSSA THERAPEUTICS, INC. | $ATOS | Daniel Mark James | Chief Financial Officer | A | Common Stock | 63000 | $0.00 | 63,000.0000 | 129,171,424 | 9999.99% | 0.05% |
| Oct. 14, 2025 | ATOSSA THERAPEUTICS, INC. | $ATOS | Daniel Mark James | Chief Financial Officer | A | Stock Option (right to buy) | 578000 | $0.00 | 578,000.0000 | 129,170,004 | 9999.99% | 0.45% |